Tyme Technologies Inc - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers section on Tyme Technologies Inc. The assessment of Tyme Technologies Inc employs data from across the internet as well as from public disclosures by Tyme Technologies Inc. This Disclosure score includes 17 United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Partnerships for the Goals'.
Tyme Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Tyme Technologies Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tyme Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tyme Technologies Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Tyme Technologies Inc report the average age of the workforce?
Sign up for free to unlockDoes Tyme Technologies Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tyme Technologies Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tyme Technologies Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Tyme Technologies Inc offer flexible work?
Sign up for free to unlockDoes Tyme Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tyme Technologies Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tyme Technologies Inc conduct supply chain audits?
Sign up for free to unlockDoes Tyme Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tyme Technologies Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tyme Technologies Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tyme Technologies Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tyme Technologies Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tyme Technologies Inc disclose water use targets?
Sign up for free to unlockDoes Tyme Technologies Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Tyme Technologies Inc have a product recall in the last two years?
Sign up for free to unlockDoes Tyme Technologies Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Tyme Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tyme Technologies Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tyme Technologies Inc disclose parental leave metrics?
Sign up for free to unlockDoes Tyme Technologies Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tyme Technologies Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tyme Technologies Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tyme Technologies Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tyme Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tyme Technologies Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tyme Technologies Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Tyme Technologies Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tyme Technologies Inc disclose its waste policy?
Sign up for free to unlockDoes Tyme Technologies Inc report according to TCFD requirements?
Sign up for free to unlockDoes Tyme Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tyme Technologies Inc disclose energy use targets?
Sign up for free to unlockDoes Tyme Technologies Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tyme Technologies Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tyme Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-19, an oral synthetically produced member of the bile acid family, which is in preclinical stage for the treatment of COVID-19 and disease variants; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; NYU School of Medicine to examine multiple aspects of SM-88 mechanisms; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.